![Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices | Neurology Genetics Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices | Neurology Genetics](https://ng.neurology.org/content/nng/7/6/e623/F1.large.jpg)
Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices | Neurology Genetics
![Muscle‐directed gene therapy corrects Pompe disease and uncovers species‐specific GAA immunogenicity | EMBO Molecular Medicine Muscle‐directed gene therapy corrects Pompe disease and uncovers species‐specific GAA immunogenicity | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/a2942442-98b3-4a59-963b-97985b17a85d/emmm202113968-abs-0001-m.jpg)
Muscle‐directed gene therapy corrects Pompe disease and uncovers species‐specific GAA immunogenicity | EMBO Molecular Medicine
A genetic disease killed Ayla's sisters. A first-of-its-kind treatment is helping her survive | CBC Radio
![Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder](https://www.mdpi.com/biomolecules/biomolecules-10-01339/article_deploy/html/images/biomolecules-10-01339-g001.png)
Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder
![Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe disease: Molecular Therapy - Methods & Clinical Development Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe disease: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/53fb272e-d955-4af0-bbf0-fc170b387610/fx1_lrg.jpg)